![](/img/cover-not-exists.png)
2315 A phase Ib study of the FGFR/VEGFR inhibitor dovitinib (D) combined with gemcitabine (G) and Capecitabine (C) in advanced pancreatic cancer patients
Ma, W.W., Fetterly, G., LeVea, C., Zhao, Y., Dy, G.K., Iyer, R., Tan, W., Brady, W., Whitworth, A., Adjei, A.A.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(16)31231-X
Date:
September, 2015
File:
PDF, 64 KB
english, 2015